High-Throughput Genomics: NGS & Arrays

Illumina sequencing by synthesis (SBS) is a massively parallel sequencing technology that has revolutionized sequencing capabilities and launched the next generation in genomic sciences. The latest Illumina sequencers unite high-performance imaging with state-of-the-art flow cells to deliver massive increases in throughput.

High-Throughput NGS to Identify Breast Cancer Targets

The Breast Cancer Atlas Project involves sequencing more than a million individual breast cancer cells to help researchers identify potential therapeutic targets.

High-Throughput Sequencing Supports Australia Genome Center Growth

Implementing high-capacity NGS allowed the Deakin Genomics Centre to expand projects for species ancient and new, large and small.

Value of a Panomics-Based Drug Discovery Approach

A large clinical study that integrates sequencing with imaging, multiomic technologies, and big data uncovers novel therapeutic targets for chronic diseases.

Recent advances in sequencing technologies have allowed for the development of genomics-based strategies to assay GWAS SNPs for potential functional relevance. Powerful combinations of high-throughput experimental assays, single-cell approaches, and computational analyses are accelerating the ability to link variants to function, and, by extension, link genotype to phenotype.

Establishing and Scaling an Efficient Genotyping Facility

Prenetics created a high-throughput genotyping laboratory to serve its growing customer base in Southeast Asia.

Polygenic Risk Scores Could Become Useful Tools in the Physician's Toolbox

Researchers discuss large GWAS studies to identify disease-associated DNA risk loci and develop PRSs for clinical validation.

Scaling Up to Genotype Thousands of Samples

Resource planning and automated genotyping workflows allowed GPBio to achieve immediate efficiency and throughput gains.